on Wednesday said it was discontinuing its heart surgery robot business as it posted a 30% drop in second-quarter operating profit on shrinking demand for COVID-19 tests.
The "use of Corindus robots for cardiology operations did not fulfill our expectations," Chief Financial Officer Jochen Schmitz said on a press call. Schmitz added it will take several years before robots for neurological operations are ready for the market.
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
출처: Reuters - 🏆 2. / 97 더 많은 것을 읽으십시오 »